Recurrent stroke in the warfarin versus aspirin in reduced cardiac ejection fraction (WARCEF) trial

Cerebrovascular Diseases

Volumn 38, Issue 3, 2014, Pages 176-181

  Pullicino, Patrick M ^a   Qian, Min ^b   Sacco, Ralph L ^c   Freudenberger, Ron ^d   Graham, Susan ^e   Teerlink, John R ^f   Mann, Douglas ^g   Di Tullio, Marco R ^b   Ponikowski, Piotr ^h   Lok, Dirk J ⁱ   Anker, Stefan D ^j   Lip, Gregory Y H ^k   Estol, Conrado ^l   Levin, Bruce ^b   Mohr, Jay P ^b   Thompson, John L P ^b   Homma, Shunichi ^b  

^a UNIVERSITY OF KENT   (United Kingdom)

^b Columbia University ^*  (United States)

^c UNIVERSITY OF MIAMI   (United States)

^d LEHIGH VALLEY HOSPITAL   (United States)

^e UNIVERSITY AT BUFFALO   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g WASHINGTON UNIVERSITY   (United States)

^h WROCLAW MEDICAL UNIVERSITY   (Poland)

ⁱ DEVENTER HOSPITAL   (Netherlands)

^j CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^k UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^l Centro Neurol de Tratamiento/Rehab   (Argentina)

more..

Author keywords

Ejection fraction; Heart failure; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; WARFARIN; ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT;

ADULT; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; FEMALE; HEART EJECTION FRACTION; HUMAN; INCIDENT ISCHEMIC STROKE; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RISK FACTOR; RISK REDUCTION; STROKE PATIENT; AGED; COMPARATIVE STUDY; HEART FAILURE; HEART STROKE VOLUME; MIDDLE AGED; STROKE;

AGED; ANTICOAGULANTS; ASPIRIN; FEMALE; FIBRINOLYTIC AGENTS; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; RECURRENCE; STROKE; STROKE VOLUME; WARFARIN;

EID: 84912088790     PISSN: 10159770     EISSN: 14219786     Source Type: Journal    
DOI: 10.1159/000365502     Document Type: Article

References (14)

1. Homma S, Thompson JL, Pullicino PM, Levin B, Freudenberger RS, Teerlink JR, Ammon SE, Graham S, Sacco RL, Mann DL, Mohr JP, Massie BM, Labovitz AJ, Anker SD, Lok DJ, Ponikowski P, Estol CJ, Lip GY, Di Tullio MR, Sanford AR, Mejia V, Gabriel AP, del Valle ML, Buchsbaum R: Warfarin and aspirin in patients with heart failure and sinus rhythm. N Engl J Med 2012; 366: 1859- 1869.
2. Massie BM, Collins JF, Ammon SE, Armstrong PW, Cleland JG, Ezekowitz M, Jafri SM, Krol WF, O'Connor CM, Schulman KA, Teo K, Warren SR: Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: The Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial. Circulation 2009; 119: 1616- 1624.
3. Eikelboom JW, Connolly SJ: Warfarin in heart failure. N Engl J Med 2012; 366: 1936-1938.
4. Pullicino PM, Thompson JLP, Sacco RL, Sanford AR, Qian K, Teerlink JR, Haddad H, Diek M, Freudenberger RS, Labovitz AJ, Di Tullio MR, Lok DJ, Ponikowski P, Anker SD, Graham S, Mann DL, Mohr JP, Homma S: Stroke in heart failure in sinus rhythm: The Warfarin versus Aspirin in Reduced Ejection Fraction trial. Cerebrovasc Dis 2013; 36: 74- 78.
5. Pullicino P, Homma S: Stroke in heart failure: Atrial fibrillation revisited? J Stroke Cerebrovasc Dis 2010; 19: 1-2.
6. Hart RG, Benavente O, McBride R, Pearce LA: Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: A meta-analysis. Ann Intern Med 1999; 131: 492-501.
7. Singer DE, Chang Y, Fang MC, Borowsky LH, Pomernacki NK, Udaltsova N, Go AS: The net clinical benefit of warfarin anticoagulation in atrial fibrillation. Ann Intern Med 2009; 151: 297-305.
8. Lahaye S, Regpala S, Lacombe S, Sharma M, Gibbens S, Ball D, Francis K: Evaluation of patients' attitudes towards stroke prevention and bleeding risk in atrial fibrillation. Thromb Haemost 2014; 111: 465-473.
9. Witt BJ, Brown RD Jr, Jacobsen SJ, Weston SA, Ballman KV, Meverden RA, Roger VL: Ischemic stroke after heart failure: A community based study. Am Heart J 2006; 152: 102-109.
10. Pullicino PM, McClure LA, Howard VJ, Wadley VG, Safford MM, Meschia JF, Anderson A, Howard G, Soliman EZ: Identifying a high stroke risk subgroup in individuals with heart failure. J Stroke Cerebrovasc Dis 2013; 22: 620-626.
11. Pullicino P, Raynor S: Is low cardiac ejection fraction a risk factor for stroke? Malta Medical Journal 2013; 25: 10-17.
12. Dries DL, Rosenberg YD, Waclawiw MA, Domanski MJ: Ejection fraction and risk of thromboembolic events in patients with systolic dysfunction and sinus rhythm: evidence for gender differences in the studies of left ventricular dysfunction trials. J Am Coll Cardiol 1997; 29: 1074-1080.
13. Liao J, Khalid Z, Scallan C, Morillo C, O'Donnell M: Noninvasive cardiac monitoring for detecting paroxysmal atrial fibrillation or flutter after acute ischemic stroke: A systematic review. Stroke 2007; 38: 2935- 2940.
14. Furie KL, Goldstein LB, Albers GW, Khatri P, Neyens R, Turakhia MP, Turan TN, Wood KA: Oral antithrombotic agents for the prevention of stroke in nonvalvular atrial fibrillation: A science advisory for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2012; 43: 3442-3453.